Replies to post #106102 on Biotech Values

[HattieTheWitch]

TEVA is a heavyweight in the generic business... if the development / manufacturing of t-enox were done by an unknown 3rd party....

the likelihood / probability of success would by less... or at the very least the perception for success would be less.

Thank you. That makes a lot of sense.

Unfortunately, that wasn't even one of my proposed explanations. :-(

I guess my question would be this: if that is the case, WHY is it the case? IOW, why would such a heavyweight "subcontract" out such things? I can think of only two explanations: 1) TEVA does not have relevant reverse-engineering expertise, and 2) TEVA does not have appropriate manufacturing facilities.

I'm sorry if I'm way off. I'm very interested, but also struggling to reach a deeper level of understanding about biotech matters.